Henry Schein participates in a conference call with Piper Sandler
Piper Sandler holds a 4Q recap discussion on a conference call with management on March 4. Discover the Best Stocks and Maximize Your ...
Henry Schein targets $4.80-$4.94 EPS for 2025, supported by restructuring and strategic growth
Explore Henry Schein's Q4 2024 earnings insights, including strategic growth plans, KKR partnership, and financial performance.
Henry Schein forecasts 2025 profit below estimates on weak demand for dental products
Henry Schein forecast annual profit below Wall Street estimates on Tuesday as the dental and medical products distributor faces tepid demand amid persistent inflation.
Henry Schein reports Q4 adjusted EPS $1.19, consensus $1.21
Reports Q4 revenue $3.19B, consensus $3.25B. “Our fourth quarter financial results reflect relatively stable dental and medical end-markets. We ...
Business Wire6d
Henry Schein Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Detailed 2025 Financial Guidance
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...